steady_state

TL3 Regular · Espoo, FI

Pharmacokinetics enthusiast, not a pharmacologist. I try to keep the half-life arithmetic honest.

Joined 15 January 2025 · last posted 5d

141 posts, newest first. Showing up to 150.

A critique that turned out to be unfair, retracted by its author Replied, post #36 · Evidence › Study critique · 23 Jul 2026 · 4 likes The strongest critiques cite the section they rely on. A critique without a page reference is an impression, however well informed. If anyone can point at the primary…
Prescription portability between countries Replied, post #106 · Access › International · 20 Jul 2026 · 0 likes Adding a null result on prescription portability between countries. I looked, carefully, and found nothing, and null results deserve posting precisely because they…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #89 · Start Here › Welcome · 8 Jul 2026 · 1 like One small courtesy that makes a large difference: put the specific question in the title. It is the single thing that most changes how quickly you get a useful reply.…
Revisiting: The best-written scientific paper you have read Replied, post #74 · Lounge › Off topic · 6 Jul 2026 · 1 like Nothing to add on the substance. Thank you for taking the question at face value.
Revisiting: Protein density versus volume when you cannot eat much Replied, post #31 · Nutrition & Training › Protein & intake · 4 Jul 2026 · 0 likes Taking post #28 at face value and following it one step further. Renal considerations around higher protein intake apply to people with existing renal impairment and…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #93 · Devices › Syringes & needles · 3 Jul 2026 · 15 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
Is "synergy" the right word for the combination data? Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 3 Jul 2026 · 21 likes Understood. Thank you for being specific about the limits of it.
Programming during a large energy deficit Replied, post #30 · Nutrition & Training › Resistance training · 2 Jul 2026 · 5 likes This follows post #27 rather than contradicting it. Maintaining load with reduced volume is a reasonable strategy during a deficit and appears in the published…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #62 · Evidence › Journal club · 27 Jun 2026 · 3 likes The honest answer on SURMOUNT-OSA is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #12 · Lounge › Off topic · 23 Jun 2026 · 2 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
Fasting versus non-fasting and which tests care Replied, post #51 · Clinical › Bloodwork · 18 Jun 2026 · 1 like Fasting versus non-fasting: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #88 · Practice › Reconstitution · 18 Jun 2026 · 23 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #20 · Documentation › Doc review · 9 Jun 2026 · 26 likes Fair, and the limits you put on it are the part I will remember.
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #84 · Evidence › Journal club · 6 Jun 2026 · 6 likes Confirming post #83 from a second method, which matters more than confirming it from a second person. People arriving without having read it should be welcome and…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #53 · Practice › Interactions · 29 May 2026 · 19 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #60 · Compounds › Tirzepatide · 17 May 2026 · 5 likes I had written a reply contradicting post #56 and deleted it. Here is what survived. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #65 · Practice › Administration · 13 May 2026 · 24 likes I had written a reply contradicting post #63 and deleted it. Here is what survived. Needle length matters less than angle for subcutaneous delivery in most people. A…
What published stability data actually covers, and what it does not Started this topic · Practice › Storage & stability · 1 May 2026 · 1 like Asking directly, because I could not find a straight answer: What published stability data actually covers, and what it does not A question about published stability…
Revisiting: Absolute versus relative contraindications Replied, post #77 · Safety › Contraindications · 28 Apr 2026 · 2 likes History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
Reading U-100 graduations, with a conversion table Replied, post #24 · Devices › Syringes & needles · 28 Apr 2026 · 8 likes I read post #20 twice before replying, because I had assumed the opposite. U-100 means the barrel is graduated for a solution containing one hundred units of insulin…
Amylin receptor signalling and satiety — what changed since Replied, post #67 · Pharmacology › Receptor biology · 23 Apr 2026 · 0 likes Receptor occupancy required for a clinical effect is not the same as full occupancy, and dose-response curves flattening at the top is what you would expect from that.
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #120 · Analytics › Mass spectrometry · 23 Apr 2026 · 0 likes On Adducts, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #63 · Outcomes › Body composition · 22 Apr 2026 · 33 likes Agreed on all of that, and I have nothing to add to it.
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #18 · Wellbeing › Sleep · 20 Apr 2026 · 0 likes Sleep quality changes reported here have several plausible contributors, and separating drug effects from weight change, from schedule change, and from anxiety is…
Follow-up: Search filters: what is missing Replied, post #78 · Meta › Site feedback · 16 Apr 2026 · 30 likes That is clearer than the version I had in my head. Thank you.
What a certificate commits its issuer to — one year on Replied, post #48 · Analytics › COA interpretation · 12 Apr 2026 · 0 likes Post #46 and I disagree about the size of the effect, not about the direction. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate…
Coming back to: Which fields on a certificate actually matter, ranked Replied, post #3 · marked as the solution · Analytics › COA interpretation · 7 Apr 2026 · 17 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #5 · Practice › Reconstitution · 2 Apr 2026 · 13 likes Where I part company with the opening post, and it is a narrow parting. Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #40 · Analytics › Mass spectrometry · 29 Mar 2026 · 8 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
Sample handling between despatch and injection Replied, post #3 · Analytics › Method validation · 27 Mar 2026 · 0 likes Sample stability during analysis is part of validation and is routinely ignored. A preparation that degrades in the autosampler over eight hours produces a…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #2 · Analytics › HPLC & UHPLC · 15 Mar 2026 · 17 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
Preprint servers and what screening they do — the long version Replied, post #4 · Evidence › Preprints · 6 Mar 2026 · 11 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion. Nothing above should…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #2 · Practice › Administration · 4 Mar 2026 · 24 likes Agreed on Pinch, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the…
CJC-1295 with and without DAC: what the modification does Replied, post #7 · Compounds › Secretagogues & GH axis · 4 Mar 2026 · 1 like Before the thread moves on from CJC-1295 — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and…
How the published trials escalated, tabulated side by side Replied, post #8 · Practice › Dosing & titration · 3 Mar 2026 · 27 likes Post #6 answers the question as asked. The question underneath it is different. When a dose reduction is the correct response to a side effect: if a side effect is…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #23 · Practice › Reconstitution · 24 Feb 2026 · 31 likes On Choosing a concentration the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Micro-titration: a disputed topic, argued properly Replied, post #38 · Practice › Dosing & titration · 23 Feb 2026 · 10 likes A methods point on micro-titration rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Mass error in ppm: the arithmetic and the caveat Replied, post #41 · Analytics › Mass spectrometry · 13 Feb 2026 · 5 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
Filter needles: when they help and what they cost you Replied, post #48 · Devices › Syringes & needles · 9 Feb 2026 · 0 likes Filing a mild objection to the consensus on filter needles. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Trifluoroacetate content and its consequences Replied, post #78 · Analytics › Impurities & related substances · 4 Feb 2026 · 14 likes Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
Why the titration planner refuses to produce a schedule below a floor Replied, post #34 · Data & Tools › Calculators · 31 Jan 2026 · 0 likes Post #33 answers the question as asked. The question underneath it is different. The thing about titration planner refuses that took me longest to accept is that a…
Trifluoroacetate content and its consequences Replied, post #27 · Analytics › Impurities & related substances · 26 Jan 2026 · 1 like Source for the trifluoroacetate content figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
A partial dose because the pen emptied mid-injection Replied, post #21 · Practice › Administration · 7 Jan 2026 · 0 likes Partial dose because the pen came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Journal club: LEADER as the historical anchor Replied, post #20 · Evidence › Journal club · 6 Jan 2026 · 6 likes I have been on both sides of the LEADER argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
[2026 update] Long-time reader, first-time poster Replied, post #38 · Lounge › Introductions · 2 Jan 2026 · 2 likes Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right. Reading it…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #12 · Documentation › Wiki requests · 26 Dec 2025 · 12 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #89 · Analytics › COA interpretation · 13 Dec 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #25 · Analytics › Method validation · 12 Dec 2025 · 16 likes Worth separating two things that post #23 runs together. A method that reports the same number for every lot is worth a second look. Real processes vary, and a total…
DXA precision and the least significant change for lean mass Replied, post #15 · Outcomes › Body composition · 23 Nov 2025 · 22 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #19 · Access › Pricing · 19 Nov 2025 · 13 likes This follows post #18 rather than contradicting it. A cheaper option that arrives slowly has a cost in the form of running out, and people rarely price that.
[2026 update] What steady state means for the decision to escalate Replied, post #135 · Practice › Dosing & titration · 18 Nov 2025 · 1 like Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
Lurking for two months before posting: was that the right call? Replied, post #25 · Start Here › Welcome · 18 Nov 2025 · 24 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
Pen dose counters: what a click does and does not guarantee Replied, post #48 · Devices › Pens & autoinjectors · 15 Nov 2025 · 1 like Reading back through, this was answered upthread and I missed it. My fault.
Prescription requirements and telehealth models Replied, post #13 · Sourcing › Regulatory · 14 Nov 2025 · 0 likes Post #10 is right about the mechanism and I think understates the practical bit. I would be cautious about generalising from the prescription requirements and…
CJC-1295 with and without DAC: what the modification does — what changed since Started this topic · Compounds › Secretagogues & GH axis · 9 Nov 2025 · 8 likes CJC-1295 with and without DAC: what the modification does — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #94 · Practice › Reconstitution · 7 Nov 2025 · 1 like The arithmetic in post #91 is right; the assumption feeding it is the part to check. Trying to state the decimal-point error position in a way that someone who…
Freeze-thaw and why one cycle is not the same as five Replied, post #18 · Practice › Storage & stability · 2 Nov 2025 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #56 · Compounds › Oral incretins · 1 Nov 2025 · 6 likes The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the injectable, which supports the effects being systemic rather…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #36 · Compounds › Semaglutide · 29 Oct 2025 · 7 likes Whatever the answer on semaglutide half-life turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
Sleep tracking data and its considerable limitations Replied, post #89 · Wellbeing › Sleep · 26 Oct 2025 · 0 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
New subcategory: rationale and scope Replied, post #97 · Meta › Announcements · 23 Oct 2025 · 4 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
New subcategory: rationale and scope Replied, post #74 · Meta › Announcements · 20 Oct 2025 · 0 likes Post #73 answers the question as asked. The question underneath it is different. My understanding of new subcategory is a few years old and may have been superseded. If…
Tracking that stops updating and then resumes — the long version Replied, post #23 · Sourcing › Logistics · 8 Oct 2025 · 5 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Micronutrient adequacy at low total intake — does this still hold? Replied, post #7 · Nutrition & Training › Protein & intake · 4 Oct 2025 · 23 likes Picking up post #4: that is the part I would want checked first. I changed my mind about Micronutrient adequacy after someone here asked me for the source and I could…
Validating a method you did not develop Replied, post #3 · Analytics › Method validation · 30 Sep 2025 · 20 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
Compounds this community declines to help with, and why Replied, post #20 · Compounds › Other compounds · 27 Sep 2025 · 9 likes Melanotan II is a non-selective melanocortin agonist, which is why its effects are not confined to pigmentation. The non-selectivity is the mechanism and not a side…
Coming back to: Why quantitation is the hard part, not detection Replied, post #67 · Analytics › Home & field testing · 19 Sep 2025 · 9 likes Confirming post #66 from a second method, which matters more than confirming it from a second person. Documenting home checks with dates and lots makes them accumulate…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #45 · Evidence › Study critique · 13 Sep 2025 · 18 likes Saving this. It is the version I will quote when the question comes round again.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #34 · Evidence › Study critique · 13 Sep 2025 · 4 likes Distinguishing three things in the Reverse causation discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #96 · Compounds › Oral incretins · 6 Sep 2025 · 18 likes Following this. I have the same question and no better information than the first post.
What a purity-only report leaves out Replied, post #7 · marked as the solution · Sourcing › Independent verification · 6 Sep 2025 · 19 likes Filing a mild objection to the consensus on purity-only. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
[2026 update] US compounding rules and how they changed Replied, post #36 · Regional › North America · 5 Sep 2025 · 0 likes Nothing to add, except that this is the answer I would give if asked.
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #43 · Practice › Storage & stability · 3 Sep 2025 · 16 likes Answering the question post #41 raises rather than the one it answers. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
Enforcement priorities versus written rules — does this still hold? Replied, post #36 · Sourcing › Regulatory · 29 Aug 2025 · 21 likes This follows post #35 rather than contradicting it. I would keep Enforcement priorities and the decision it usually gets used for separate in this thread. They are…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #103 · Clinical › Comorbidities · 29 Aug 2025 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
Preparing for an appointment: one page, three questions Replied, post #33 · Clinical › Prescriber conversations · 23 Aug 2025 · 1 like Second this, and I would have said it less carefully.
Are there stupid questions here? A staff answer, at length Replied, post #91 · Start Here › Welcome · 20 Aug 2025 · 14 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #65 · Devices › Cold chain · 19 Aug 2025 · 0 likes Reading back through the Airline travel threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
Why the timeline is on the right and not the left Replied, post #55 · Meta › Site feedback · 16 Aug 2025 · 0 likes Worth separating two things that post #53 runs together. Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #43 · Evidence › Journal club · 16 Aug 2025 · 22 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #40 · Sourcing › Vendor reports · 15 Aug 2025 · 1 like Post #39 is right about the mechanism and I think understates the practical bit. Two questions I would want answered before drawing anything from the vendor…
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #23 · Practice › Dosing & titration · 9 Aug 2025 · 4 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #41 · Compounds › Secretagogues & GH axis · 6 Aug 2025 · 10 likes Coming back to post #38, because the follow-up matters more than the original answer. On analysis: these are short peptides and generally straightforward…
Trust level 3 requirements: a clarification Replied, post #3 · Meta › Announcements · 2 Aug 2025 · 5 likes Everything in the opening post holds. The case it does not cover is the one I have. I keep a log for trust level 3 requirements specifically because my memory of it…
Coming back to: Official shortage notices and what they authorise Replied, post #76 · Access › Shortages · 1 Aug 2025 · 26 likes Speaking only to Official shortage notices as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread…
Coming back to: When "no data" is the complete and final answer Replied, post #63 · Compounds › Other compounds · 29 Jul 2025 · 19 likes Where I part company with post #61, and it is a narrow parting. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which…
Which panel is worth repeating and which is worth ignoring Replied, post #65 · Clinical › Bloodwork · 21 Jul 2025 · 9 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Antibiotics and a course of something with delayed emptying Replied, post #83 · Practice › Interactions · 6 Jul 2025 · 0 likes Adding a null result on antibiotics. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
What a documentation review can and cannot tell you Replied, post #11 · Sourcing › Independent verification · 21 Jun 2025 · 0 likes Everything in post #9 holds. The case it does not cover is the one I have. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
A supplier that answers analytical questions with restated claims Replied, post #96 · Sourcing › Red flags · 13 Jun 2025 · 11 likes Taking post #95 at face value and following it one step further. Answering the supplier question as asked, then the question I think is meant. As asked: yes, with the…
A report I filed that turned out to be wrong, and the correction Replied, post #94 · Sourcing › Vendor reports · 9 Jun 2025 · 19 likes Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is the unit and it should be in every report. It reads as pedantry…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #65 · Wellbeing › Mental health · 7 Jun 2025 · 2 likes Second-hand on history of disordered eating, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Reading a trial's population section before its results — does this still hold? Replied, post #155 · Evidence › Trials · 28 May 2025 · 0 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #32 · Devices › Cold chain · 28 May 2025 · 0 likes Summer routes and winter routes are genuinely different problems, and a supplier that changes its packing between them is doing something rather than nothing. The rule…
Follow-up: Is "synergy" the right word for the combination data? Replied, post #3 · marked as the solution · Compounds › Cagrilintide & amylin analogues · 26 May 2025 · 12 likes Worth separating two things that the opening post runs together. Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and…
Travel coolers and how long they really hold — the long version Replied, post #17 · Devices › Cold chain · 22 May 2025 · 25 likes Adding the measurement that post #16 says would settle it. Second-hand on Travel coolers, so weight it accordingly — someone whose method I trust told me this and I…
Pregnancy as an absolute contraindication Replied, post #34 · Safety › Contraindications · 18 May 2025 · 16 likes Anyone posting a contraindication claim should include the source. Without one it circulates and hardens. The variance between people here is larger than the effect…
Reading a trial's population section before its results — does this still hold? Replied, post #102 · Evidence › Trials · 14 May 2025 · 0 likes Post #98 put the caveat in the right place and I want to underline it. Safety findings from a trial powered for efficacy are underpowered by construction. Absence of a…
A well-designed study with a badly written abstract Replied, post #75 · Evidence › Study critique · 11 May 2025 · 0 likes One more thing on well-designed study that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #44 · Compounds › Repair & healing peptides · 11 May 2025 · 8 likes Answering the question post #40 raises rather than the one it answers. The distinction between "no evidence it works" and "evidence it does not work": we have the first…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #101 · Devices › Cold chain · 11 May 2025 · 9 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
Reading a trial's population section before its results — does this still hold? Replied, post #87 · Evidence › Trials · 10 May 2025 · 19 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #39 · Sourcing › Independent verification · 2 May 2025 · 21 likes Janoshik would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #13 · Compounds › Retatrutide · 1 Apr 2025 · 0 likes Before the thread moves on from Retatrutide mass and identity — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted…
Journal club: SURMOUNT-1, read without the press release Replied, post #85 · Evidence › Journal club · 27 Mar 2025 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Why cagrilintide alone is discussed so much less than in combination Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 22 Mar 2025 · 0 likes Where the cagrilintide alone reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #124 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes Thank you — that answers what I came here to find out.
Retatrutide dose escalation in the published trials Replied, post #7 · Compounds › Retatrutide · 12 Mar 2025 · 32 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #13 · Analytics › Impurities & related substances · 17 Feb 2025 · 8 likes Relative response factors mean impurities are not detected in proportion to how much of them is present. A one per cent peak is not one per cent by mass unless the…
Distinguishing a deletion sequence by mass alone Replied, post #62 · Analytics › Mass spectrometry · 8 Feb 2025 · 0 likes Combining a chromatographic result with a mass result is genuinely orthogonal confirmation. Either alone leaves a specific class of problem invisible, and the two…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #6 · Analytics › Mass spectrometry · 7 Feb 2025 · 24 likes Response in electrospray is not proportional to abundance across different species. Using peak intensities from a mass spectrum to estimate proportions is a mistake…
Adjudicated events and why the definition matters — the long version Replied, post #4 · Evidence › Trials · 7 Feb 2025 · 9 likes Two questions I would want answered before drawing anything from the Adjudicated events data above: how were the cases selected, and what happened to the ones that…
Oxidation and deamidation mass shifts, tabulated Replied, post #45 · Analytics › Mass spectrometry · 30 Jan 2025 · 0 likes Post #44 is right about the mechanism and I think understates the practical bit. Sample preparation for mass spectrometry can itself introduce modifications,…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #108 · Evidence › Journal club · 28 Jan 2025 · 25 likes I read post #106 twice before replying, because I had assumed the opposite. What I would want before treating SURPASS-2 as settled: the method, the sample, and whether…
Follow-up: What other technical communities get right that we do not Replied, post #2 · Lounge › Off topic · 19 Jan 2025 · 3 likes Unserious but true: I can now identify a certificate template at a glance and I have no professional use for that skill whatsoever. The part I am sure of is shorter…
[2026 update] New subcategory: rationale and scope Replied, post #107 · Meta › Announcements · 30 Dec 2024 · 0 likes The most useful reply I ever got about New subcategory was a request to state my units. It sounds like pedantry and it has saved me twice.
Follow-up: Dead volume across syringe and needle combinations Replied, post #90 · Devices › Syringes & needles · 29 Dec 2024 · 21 likes Picking up post #89: that is the part I would want checked first. My understanding of Dead volume across syringe is a few years old and may have been superseded. If it…
Building a sensible monitoring schedule with your prescriber Replied, post #18 · Clinical › Bloodwork · 18 Dec 2024 · 15 likes Answering the question post #15 raises rather than the one it answers. Agreed on building a sensible monitoring schedule, with one qualification that I think matters.…
What would change my mind about repair peptides: a specific answer — one year on Replied, post #13 · Compounds › Repair & healing peptides · 18 Dec 2024 · 9 likes Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.
[2026 update] New subcategory: rationale and scope Replied, post #73 · Meta › Announcements · 17 Dec 2024 · 4 likes This follows post #70 rather than contradicting it. One question about the transition rather than the policy: what happens to topics that are in flight when it takes…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #93 · Analytics › Method validation · 12 Dec 2024 · 4 likes My experience of stability-indicating method contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience…
Injection-site reactions: describing them precisely enough to be useful Replied, post #51 · Practice › Side effects · 6 Dec 2024 · 11 likes Injection-site reactions are usually local, brief and unremarkable. A reaction spreading over a day, or accompanied by systemic symptoms, is a different thing and needs…
Asking about a compound your prescriber has not heard of — one year on Replied, post #12 · Clinical › Prescriber conversations · 5 Dec 2024 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Converting between mg/mL and units per dose, both directions Replied, post #115 · Practice › Reconstitution · 4 Dec 2024 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #49 · Compounds › Semaglutide · 28 Nov 2024 · 12 likes Building on post #48 rather than restating it. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #88 · Clinical › Prescriber conversations · 22 Nov 2024 · 11 likes Everything in post #86 holds. The case it does not cover is the one I have. A question phrased as "what would you want to see before considering X" is answerable and is…
EMA product information as a primary source — does this still hold? Replied, post #128 · Regional › European Union · 18 Nov 2024 · 17 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #45 · Compounds › Semaglutide · 17 Nov 2024 · 28 likes Post #43 answers the question as asked. The question underneath it is different. Semaglutide's structure is a modified backbone with a C18 diacid attached through a…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #19 · Access › Insurance & coverage · 8 Nov 2024 · 3 likes Fair, and the limits you put on it are the part I will remember.
Converting between mg/mL and units per dose, both directions Replied, post #56 · Practice › Reconstitution · 19 Oct 2024 · 12 likes Picking up post #54: that is the part I would want checked first. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common…
Requesting a page: what makes a good request — what changed since Replied, post #112 · Documentation › Wiki requests · 12 Oct 2024 · 20 likes Post #109 describes the usual case. This is about the unusual one. Scope creep: if you think a page is attempting too much and should be split into multiple pages, that…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #82 · Analytics › COA interpretation · 12 Oct 2024 · 9 likes Taking post #79 at face value and following it one step further. Where two documents for the same lot disagree, the useful question is which was measured and which was…
Requesting a page: what makes a good request — what changed since Replied, post #99 · Documentation › Wiki requests · 12 Oct 2024 · 0 likes The strongest case for a new document is a question that recurs and has a good answer buried in a reply. That is the promotion criterion as written.
Second pass at: Hoarding and why it makes a shortage worse Replied, post #77 · Access › Shortages · 12 Oct 2024 · 0 likes Post #76 is right about the mechanism and I think understates the practical bit. Pharmacy-level availability varies enormously during a shortage, so two honest accounts…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #134 · Nutrition & Training › Hydration & electrolytes · 5 Oct 2024 · 4 likes This follows post #131 rather than contradicting it. The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie deficit,…
SURPASS-2 and the comparator dose question that will not go away Replied, post #18 · Compounds › Tirzepatide · 19 Sep 2024 · 13 likes Thank you — that answers what I came here to find out.
A rising related-substance total over six months: degradation or method drift? Replied, post #32 · Analytics › Impurities & related substances · 4 Sep 2024 · 31 likes Taking post #29 at face value and following it one step further. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #2 · Practice › Dosing & titration · 6 Jul 2024 · 7 likes Splitting a weekly dose would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Cold packs, phase-change material, and what survives ten days Replied, post #66 · Sourcing › Logistics · 3 Jul 2024 · 7 likes Confirming post #63 from a second method, which matters more than confirming it from a second person. At what point is a parcel genuinely a problem: if it was…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #21 · Practice › Dosing & titration · 1 Jul 2024 · 2 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
Follow-up: Dead volume across syringe and needle combinations Replied, post #4 · Devices › Syringes & needles · 27 Jun 2024 · 2 likes Adding the measurement that post #3 says would settle it. I have three months of notes on Dead volume across syringe and the honest summary is that the trend is real…